NMNAT2 and lung adenocarcinoma: DGUOK silencing in lung adenocarcinoma cells reduces the NAD+ levels and downregulates NMNAT2 expression (both at the mRNA and at the protein level) through a mechanism that does not depend on mitochondria complex I activity [114].